UniCycive Therapeutics Inc (UNCY)

[Whalatane]

So a note on ARDX's qtly report and Xphozah .
Last part of CC was cutting out
BUT
Xphozah generated $25 m in rev in one Qt ...with no Medicare coverage !!
90% of those on dialysis are on Medicare
OLC once approved ..will be 100% reimbursed by Medicare for the first 2 yrs ...declining coverage after that .

So we have Xphozah generating $25 in rev for the Qt with only 10% of the dialysis population having reimbursement covered .
And 50% of those on it , complain of diarrhea !!!!.

Just shows me how much dialysis patients hate their current pho binders and how desperate Nephrologists are to get their patients onto something better ...to get their serum pho levels to goal

OLC ..100% reimbursed once in TDAPA ...diarreha not a major concern

Kiwi